A detailed history of Belpointe Asset Management LLC transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Belpointe Asset Management LLC holds 84,929 shares of ASRT stock, worth $61,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,929
Previous 95,679 11.24%
Holding current value
$61,998
Previous $64,000 15.63%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 22, 2025

SELL
$0.53 - $0.71 $5,697 - $7,632
-10,750 Reduced 11.24%
84,929 $54,000
Q1 2025

May 20, 2025

BUY
$0.67 - $0.88 $64,104 - $84,197
95,679 New
95,679 $64,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $35.2M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.